Home » Topics » Collaboration, BioWorld Science

Collaboration, BioWorld Science
RSS

Vectura and Sandoz revise VR-315 agreement for U.S.

March 18, 2010

ALS Therapy Development Institute and Aestus to test potential ALS treatments

March 18, 2010

Tekmira and Pfizer collaborate on stable nucleic acid-lipid particle technology

March 17, 2010

Lilly to acquire worldwide license to Acrux's testosterone solution Axiron

March 17, 2010

Medicago and MOU partner to commercially develop influenza vaccines in Japan

March 17, 2010

LLS and Forma to develop new therapies for diffuse large B-cell lymphoma

March 17, 2010

Sigma-Aldrich to sell Pfizer's small-molecule compounds to researchers

March 16, 2010

Orexigen and Patheon enter into exclusive manufacturing agreement for Contrave

March 16, 2010

Eisai and Johns Hopkins to collaborate on development GCPII inhibitors

March 16, 2010

Ipsen grants Rhythm worldwide license for two programs in metabolic disorders

March 15, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...